A Randomized, prospektivE pilot triAL on exercising during treatment in FItting TransplaNt Eligible patientS with Symptomatic multiple myeloma

A Randomized, prospektivE pilot triAL on exercising during treatment in FItting TransplaNt Eligible patientS with Symptomatic multiple myeloma - REAL-FITNESS

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022250

Enrollment

Registered

2020-10-05

Start date

2021-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: exersicing Group 2: no exercising

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Symptomatic MM at inital diagnosis. (2) Planned induction therapy with VCD followed by transplantation at UKF.

Exclusion criteria

Exclusion criteria: (1) Spinal cord compression or unstable fractures. (2) Severe cardial diseases or arrythmia (NYHAE 3-4). (3) Chronic cardial diseases (NYHAE 3-4). (4) Other severe diseases not allowing physical activity and exercising (e. g. severe neurological disorder).

Design outcomes

Primary

Measure	Time frame
Feasibility with ist aim of a multicentric, randomised clinical trial.	—

Secondary

Measure	Time frame
(1) Evaluation of Revised Myeloma Comorbiditiy Index (R-MCI) due to differences in physical active vs. inactive MM-patients. (2) Event Free Survival (EFS).	—

Countries

Germany

Contacts

Public ContactMandy-Deborah Möller

Universitätsklinikum Freiburg

mandy-deborah.moeller@uniklinik-freiburg.de+4976127078171

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026